NCT03797482 A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer
| NCT ID | NCT03797482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tata Memorial Hospital |
| Condition | Breast Cancer Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-11-27 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-11-27 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To understand the effects induced by acute hypoxia that sets in during surgery in breast cancer. To study this, clinical samples (Tumor biopsies) will be obtained during the surgery after partial devascularisation (sample B) and stored for future genomic and proteonomic evaluations.
Eligibility Criteria
Inclusion Criteria: 1. Clinically diagnosis of breast cancer (by FNAC or Biopsy) 2. Not received any chemotherapy or surgical intervention except core biopsy. 3. Planed for Breast cancer surgery 4. Willing to give consent for the study Exclusion Criteria: 1. Clinically diagnosis of Metastatic breast cancer 2. Received any anticancer therapy
Contact & Investigator
Rajendra Badwe
PRINCIPAL INVESTIGATOR
Director, tata Memorial Centre
Frequently Asked Questions
Who can join the NCT03797482 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03797482 currently recruiting?
Yes, NCT03797482 is actively recruiting participants. Contact the research team at drjoshishalaka@gmail.com for enrollment information.
Where is the NCT03797482 trial being conducted?
This trial is being conducted at Mumbai, India.
Who is sponsoring the NCT03797482 clinical trial?
NCT03797482 is sponsored by Tata Memorial Hospital. The principal investigator is Rajendra Badwe at Director, tata Memorial Centre. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.